Upon intravenous injection into an SKOV3 xenograft mouse model, the dual ligand-modified system showed significantly higher tumor accumulation and more effective MTH1 gene disruption than the respective mono ligand-modified delivery systems. The gene discussed is NUDT1; the disease is neoplasm.